TY - JOUR
T1 - The principle and the potential approach to ros-dependent cytotoxicity by non-pharmaceutical therapies
T2 - Optimal use of medical gases with antioxidant properties
AU - Noda, Mami
AU - Fujita, Kyota
AU - Lee, Chih Hung
AU - Yoshioka, Tohru
PY - 2011/7
Y1 - 2011/7
N2 - Regulation of cellular redox balances is important for the homeostasis of human health. Thus, many important human diseases, such as inflammation, diabetes, glaucoma, cancers, ischemia and neurodegenerative diseases, have been investigated in the field of reactive oxygen species (ROS) and oxidative stress. To overcome the harmful effect of oxidative stress and ROS, one can directly eliminate them by medical gases such as carbon monoxide (CO), hydrogen sulphide (H2S), and molecular hydrogen (H2), or one can induce ROSresistant proteins and antioxidant enzymes to antagonize oxidative stresses. This article reviews the molecular mechanisms how these medical gasses work as antioxidants, and how ROS resistant proteins are produced in the physiological context. Targeted therapeutic modalities to scavenge or prevent ROS might be applied in the prevention and treatment of ROS-related diseases in the near future.
AB - Regulation of cellular redox balances is important for the homeostasis of human health. Thus, many important human diseases, such as inflammation, diabetes, glaucoma, cancers, ischemia and neurodegenerative diseases, have been investigated in the field of reactive oxygen species (ROS) and oxidative stress. To overcome the harmful effect of oxidative stress and ROS, one can directly eliminate them by medical gases such as carbon monoxide (CO), hydrogen sulphide (H2S), and molecular hydrogen (H2), or one can induce ROSresistant proteins and antioxidant enzymes to antagonize oxidative stresses. This article reviews the molecular mechanisms how these medical gasses work as antioxidants, and how ROS resistant proteins are produced in the physiological context. Targeted therapeutic modalities to scavenge or prevent ROS might be applied in the prevention and treatment of ROS-related diseases in the near future.
UR - http://www.scopus.com/inward/record.url?scp=80052244756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052244756&partnerID=8YFLogxK
U2 - 10.2174/138161211797052600
DO - 10.2174/138161211797052600
M3 - Review article
C2 - 21736540
AN - SCOPUS:80052244756
SN - 1381-6128
VL - 17
SP - 2253
EP - 2263
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 22
ER -